- Home
- Equipment
- usa california
- covid 19 novel vaccination
Refine by
Covid 19 Novel Vaccination Equipment Supplied In Usa California
7 equipment items found
Manufactured by:Masimo Corp based inIrvine, CALIFORNIA (USA)
Masimo SafetyNet-OPEN is a complete, easy-to-implement solution to help you safely bring people back into the workplace and keep them ...
Manufactured by:IGeneX based inMilpitas, CALIFORNIA (USA)
IGeneX is now offering the COV5T SARS-CoV-2 Vaccine Response Test Panel, which tests for antibody response and T-cell response. This comprehensive test panel gives patients the ability to monitor their overall response to the ...
Manufactured by:Meissa Vaccines, Inc. based inRedwood City, CALIFORNIA (USA)
The attenuation of a virus to produce a vaccine must balance reducing its virulence while retaining its ability to stimulate an effective immune response, or immunogenicity. Natural RSV infection does not stimulate a robust immune response, and immunity following SARS-CoV-2 infection wanes, so vaccine technologies that enhance immunogenicity are required. AttenuBlock is Meissa's proprietary ...
Manufactured by:Meissa Vaccines, Inc. based inRedwood City, CALIFORNIA (USA)
Meissa is developing a live attenuated COVID-19 vaccine candidate, MV-014-212, to induce mucosal and systemic immunity and protect against SARS-CoV-2, the novel coronavirus that causes COVID-19. Like Meissa’s RSV vaccine candidate, MV-014-212 offers significant potential ...
Manufactured by:Meissa Vaccines, Inc. based inRedwood City, CALIFORNIA (USA)
Respiratory viruses are one of the biggest threats to human health. Vaccines are the most effective healthcare tool to combat infectious diseases and have saved more lives than any other type of medicine. Meissa is dedicated to creating safe, potent, stable, and accessible intranasal live attenuated vaccines that can prevent infection and disease. Meissa’s RSV and COVID-19 live attenuated ...
Manufactured by:AIVITA Biomedical, Inc. based in, CALIFORNIA (USA)
AIVITA Biomedical is using its patient-specific vaccine platform to develop a rapidly scalable vaccine candidate, AV-COVID-19, for the novel coronavirus (SARS-CoV-2). AIVITA’s personalized vaccine begins with a basic blood draw, from which the recipient’s own immune cells are ...
Manufactured by:Pfizer Inc. based in, NEW YORK (USA)
The Pfizer-BioNTech COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. The emergency use of this product is only authorized for the duration of the declaration ...